A high level medical panel of US government advisors was meeting Tuesday to decide whether to authorize the Pfizer Covid-19 vaccine in five-to-11-year-olds, likely paving the way for younger children to get their shots within weeks.
from US News Headlines, Latest USA News, US news live on Times of India https://ift.tt/3CuiHmk
from US News Headlines, Latest USA News, US news live on Times of India https://ift.tt/3CuiHmk
Comments
Post a Comment